The researchers tested suramin,  a well-known inhibitor of  purinergic signaling used medically for the treatment of African  sleeping sickness since shortly after it was synthesized in 1916 -- in  mice. They found that this APT mediator corrected autism-like symptoms  in the animal model, even if the treatment was started well after the  onset of symptoms. The drug restored 17 types of multi-symptom  abnormalities including normalizing brain synapse structure,  cell-to-cell signaling, social behavior, motor coordination and  normalizing mitochondrial metabolism.
 
"The striking effectiveness shown in this study using APT to  'reprogram' the cell danger response and reduce inflammation showcases  an opportunity to develop a completely new class of anti-inflammatory  drugs to treat autism and several other disorders," Naviaux said.
Ref : http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0057380
 
 Drug treatment corrects autism symptoms in mouse model